University of Aberdeen, Respiratory Group, Division of Applied Health Sciences

United Kingdom

Aberdeen is an international university built on serving one of the most dynamic regions of Europe. With over 16,000 students from more than 120 nationalities and over 3000 staff the University is at the forefront of teaching and research in medicine, the humanities and sciences. Some University of Aberdeen successes include: 5 Nobel Laureates; the generation of 21 spin- off companies and mover 400 patents pending, high quality teaching with over 89% subjects rated Excellent/Highly Satisfactory; 97% of graduates entering directly into work, further study or training within 6 months; 85% of academic staff who are research active and a trebling of research income in the last decade. Capital expenditure 1999-2009 totalled £229 million, with a further £148 million to be invested in infrastructure to 2019.

The University of Aberdeen has been involved in European projects since framework 3 and has, to date, been successful in participating in more than 700 grants funded by the European Commission, including 10 ERC Grants. The University has also been successful in securing a number of grants under schemes such as ESF, Socrates, Interreg, COST and Leonardo.

*The University of Aberdeen terminated its participation in the project as the research team moved to the University of Stirling

Read more on www.abdn.ac.uk

University of Aberdeen, Respiratory Group, Division of Applied Health Sciences